MKI67 and neoplasm: Using immunohistochemistry (IHC) analyses, we found a similar trend of Ki-67 expression in tumor tissues, as the combo of DDP and PX-478 further more reduced tumor Ki-67 expression than the single use of either drug (Figure 6C).